Last updated: 2026-09-09 12:05:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Bausch Health Companies Inc. (BHC) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $6.40, with a market capitalization of $2.45B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $4.33 to $8.00. This page covers its latest market performance, valuation, price trends and company information.
$2.45B | |
$6.45 | |
$34.80 | |
$3.96 | |
$6.43 | |
422.00 | |
3.57M | |
-- | |
$8.00 | |
$4.33 | |
-- | |
-- |
Bausch Health Companies Inc. (BHC) is trading at $6.40 in pre-market trading as of 2026-09-09 12:03:00, down 0.47% ($0.03) from the previous close of $6.43
Pre-market trading shows how investors are pricing BHC before the regular session opens. The current pre-market price is near the previous close, indicating cautious early trading sentiment.
Over the past seven days, Bausch Health Companies Inc. (BHC) moved from $6.32 to $6.40, representing a gain of 1.27% ($0.08).
The stock traded between $6.14 and $6.99 during the period. The latest price is near the lower end of the 7-day range, indicating moderate upward.
The average daily volume was 2.83 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 56.4%
BHC is currently trading at $6.40, placing it 56.4% of the way from its 52-week low of $4.33 to its 52-week high of $8.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 20300 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Bausch Health Companies Inc. (BHC) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.